University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Laura Blackburn.

Abstract not available

This talk is part of the Cambridge Oncology Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2020 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity